A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients

Clinical trial NCT02691975 · UNKNOWN

Trial details

NCT number: NCT02691975
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hormone Refractory Prostate Cancer Metastatic Prostate Carcinoma

Start date: 2016-04-12
Primary completion: 2020-12-01
Enrollment: 197

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.